Date: Thursday 13th November 2025 Time: 16:00-17:00 GMT | 17:00-18:00 CET | 11:00-12:00 EST Presenters: Cesar Torres and Suzie Cro Chair: Kevin Ding Location: Online via Zoom
Who is this event intended for? Anyone interested in hearing more about missing data.
What is the benefit of attending? o gain a better understanding about missing data: tipping point methodology to evaluate sensitivity to potential violations in missing data assumptions and the handling of partially observed trial data after treatment withdrawal.
This event is free to attend for both Members of PSI and Non-Members.
Please join us to hear Cesar Torres (FDA) and Suzie Cro (Imperial College London) present their recent work.
1. Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt: A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions - https://onlinelibrary.wiley.com/doi/10.1002/pst.70002
2. Suzie Cro, James H. Roger, James R. Carpenter: Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple Imputation - https://onlinelibrary.wiley.com/doi/10.1002/pst.2416
Post presentation discussions to information to follow.
PSI Journal Club is sponsored by Wiley. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members
Speaker details
Speaker
Biography
Kevin Ding, Ocular Therapeutix
Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA
Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London
Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.
Date: Thursday 13th November 2025 Time: 16:00-17:00 GMT | 17:00-18:00 CET | 11:00-12:00 EST Presenters: Cesar Torres and Suzie Cro Chair: Kevin Ding Location: Online via Zoom
Who is this event intended for? Anyone interested in hearing more about missing data.
What is the benefit of attending? o gain a better understanding about missing data: tipping point methodology to evaluate sensitivity to potential violations in missing data assumptions and the handling of partially observed trial data after treatment withdrawal.
This event is free to attend for both Members of PSI and Non-Members.
Please join us to hear Cesar Torres (FDA) and Suzie Cro (Imperial College London) present their recent work.
1. Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt: A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions - https://onlinelibrary.wiley.com/doi/10.1002/pst.70002
2. Suzie Cro, James H. Roger, James R. Carpenter: Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple Imputation - https://onlinelibrary.wiley.com/doi/10.1002/pst.2416
Post presentation discussions to information to follow.
PSI Journal Club is sponsored by Wiley. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members
Speaker details
Speaker
Biography
Kevin Ding, Ocular Therapeutix
Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA
Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London
Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.
Date: Thursday 13th November 2025 Time: 16:00-17:00 GMT | 17:00-18:00 CET | 11:00-12:00 EST Presenters: Cesar Torres and Suzie Cro Chair: Kevin Ding Location: Online via Zoom
Who is this event intended for? Anyone interested in hearing more about missing data.
What is the benefit of attending? o gain a better understanding about missing data: tipping point methodology to evaluate sensitivity to potential violations in missing data assumptions and the handling of partially observed trial data after treatment withdrawal.
This event is free to attend for both Members of PSI and Non-Members.
Please join us to hear Cesar Torres (FDA) and Suzie Cro (Imperial College London) present their recent work.
1. Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt: A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions - https://onlinelibrary.wiley.com/doi/10.1002/pst.70002
2. Suzie Cro, James H. Roger, James R. Carpenter: Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple Imputation - https://onlinelibrary.wiley.com/doi/10.1002/pst.2416
Post presentation discussions to information to follow.
PSI Journal Club is sponsored by Wiley. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members
Speaker details
Speaker
Biography
Kevin Ding, Ocular Therapeutix
Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA
Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London
Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.
Date: Thursday 13th November 2025 Time: 16:00-17:00 GMT | 17:00-18:00 CET | 11:00-12:00 EST Presenters: Cesar Torres and Suzie Cro Chair: Kevin Ding Location: Online via Zoom
Who is this event intended for? Anyone interested in hearing more about missing data.
What is the benefit of attending? o gain a better understanding about missing data: tipping point methodology to evaluate sensitivity to potential violations in missing data assumptions and the handling of partially observed trial data after treatment withdrawal.
This event is free to attend for both Members of PSI and Non-Members.
Please join us to hear Cesar Torres (FDA) and Suzie Cro (Imperial College London) present their recent work.
1. Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt: A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions - https://onlinelibrary.wiley.com/doi/10.1002/pst.70002
2. Suzie Cro, James H. Roger, James R. Carpenter: Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple Imputation - https://onlinelibrary.wiley.com/doi/10.1002/pst.2416
Post presentation discussions to information to follow.
PSI Journal Club is sponsored by Wiley. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members
Speaker details
Speaker
Biography
Kevin Ding, Ocular Therapeutix
Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA
Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London
Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.
Date: Thursday 13th November 2025 Time: 16:00-17:00 GMT | 17:00-18:00 CET | 11:00-12:00 EST Presenters: Cesar Torres and Suzie Cro Chair: Kevin Ding Location: Online via Zoom
Who is this event intended for? Anyone interested in hearing more about missing data.
What is the benefit of attending? o gain a better understanding about missing data: tipping point methodology to evaluate sensitivity to potential violations in missing data assumptions and the handling of partially observed trial data after treatment withdrawal.
This event is free to attend for both Members of PSI and Non-Members.
Please join us to hear Cesar Torres (FDA) and Suzie Cro (Imperial College London) present their recent work.
1. Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt: A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions - https://onlinelibrary.wiley.com/doi/10.1002/pst.70002
2. Suzie Cro, James H. Roger, James R. Carpenter: Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple Imputation - https://onlinelibrary.wiley.com/doi/10.1002/pst.2416
Post presentation discussions to information to follow.
PSI Journal Club is sponsored by Wiley. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members
Speaker details
Speaker
Biography
Kevin Ding, Ocular Therapeutix
Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA
Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London
Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.
Date: Thursday 13th November 2025 Time: 16:00-17:00 GMT | 17:00-18:00 CET | 11:00-12:00 EST Presenters: Cesar Torres and Suzie Cro Chair: Kevin Ding Location: Online via Zoom
Who is this event intended for? Anyone interested in hearing more about missing data.
What is the benefit of attending? o gain a better understanding about missing data: tipping point methodology to evaluate sensitivity to potential violations in missing data assumptions and the handling of partially observed trial data after treatment withdrawal.
This event is free to attend for both Members of PSI and Non-Members.
Please join us to hear Cesar Torres (FDA) and Suzie Cro (Imperial College London) present their recent work.
1. Cesar Torres, Gregory Levin, Daniel Rubin, William Koh, Rebecca Chiu, Thomas Permutt: A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions - https://onlinelibrary.wiley.com/doi/10.1002/pst.70002
2. Suzie Cro, James H. Roger, James R. Carpenter: Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference-Base Centred Multiple Imputation - https://onlinelibrary.wiley.com/doi/10.1002/pst.2416
Post presentation discussions to information to follow.
PSI Journal Club is sponsored by Wiley. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time. Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members
Speaker details
Speaker
Biography
Kevin Ding, Ocular Therapeutix
Kevin completed his graduate studies in biostatistics from University of Massachusetts at Amherst. He has over 16 years experience working as a biostatistician in various pharmaceutical companies, including J&J, Novartis and AstraZeneca. He is currently working as a statistical consultant for Ocular Therapeutix. Kevin's research interests include estimand, missing data imputation and adaptive design. He presented the topic of missing data and estimand in JSM and PSI webinar before. The methods in these presentations were applied and implemented in several phase 3 clinical trials he worked on.
Cesar Torres, FDA
Cesar completed his graduate studies at the University of Washington’s Department of Biostatistics. He now works at the FDA’s Center for Drug Evaluation and Research in the Office of Biostatistics (OB) as the acting team leader for the statistical review team supporting the Division of Rheumatology and Transplant Medicine. He also serves as a member of the OB estimands working group, as well as the chair of the OB missing data working group. Cesar’s research interests include estimands, missing data, the evaluation of safety and benefit-risk, and finite sample properties of select statistical methodologies.
Suzie Cro, Imperial College London
Dr Suzie Cro is Head of Trial Methodology and co-Head of the Statistics section at Imperial Clinical Trials Unit (ICTU), Imperial College London. She has over 15 years’ experience in the design and analysis of clinical trials and other interventional studies across clinical areas including dermatology, musculoskeletal, dementia and opiate addiction. Her core statistical research interests include translating the ICH-E9-R1 addendum on estimands and sensitivity analysis in clinical trials into best practice for researchers and patients and the public, handling missing data and transparency in the statistical analysis of clinical trials. She obtained her PhD in medical statistical from the London School of Hygiene and Tropical Medicine.
Upcoming Events
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI Book Club: Change: How organisations achieve hard-to-image results in uncertain and volatile times
Organizations have to adapt to the transforming landscape of our industry to ensure they continue to be successful in the future. Many of us are feeling the impact of organizational change. By reading John P Kotter’s book we can understand about organizational change and learn how to thrive, rather than just survive, through change.
Change, by John P Kotter (and his team), is a summary of all that he has learned over his decades of research and leading change. His book describes why many current approaches to change are inadequate and explains why new solutions need to give people a voice and a role in a new, change-embracing organization.
Develop your understanding of organisational change and become empowered to be part of your organisation’s change, by reading Change by John P Kotter and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply knowledge from the book in-between sessions.
PSI Book Club: Another Door Opens – Book Club Special Event
This is a Book Club Special Event in response to the changes in our industry and as a supportive move to create community and connection for those navigating redundancy and uncertainty. Read the book in advance of the book club session then join the zoom call to discuss ideas. There will be breakout groups to connect with others, exchange experiences of how the book has helped, and offer support.
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Training Course: Propensity Scores: Practical Application in Non-randomised Studies
The course will introduce the topic of propensity scores and the use of external data. Covering the topics of matching and weighting as well as more advance topics of high dimension propensity scores, multi-valued treatments, double robustness and time-varying scenarios. There will be the opportunity to participate in some hands on practical exercises in R.
This two-afternoon virtual course provides a practical introduction to adaptive clinical trials, focusing on the concepts, applications, and regulatory principles outlined in ICH E20 through real-world examples and case studies.
PSI Careers - MEDMathS: Medicine Empowered by Data, Maths and Statistics
Date: Wednesday 4th November 2026
A careers talk about medical statistics and how it plays a crucial role in developing new medicines. Learn about the field of medical statistics and how it plays a crucial role in developing groundbreaking new medicines, vaccines and healthcare products.
Date: 18 November 2026
This is an excellent opportunity for students to find out more about the field of medical statistics, talk to people from different organisations and make contacts for the future. All students currently studying for a mathematics or statistics-related BSc, MSc or PhD are invited to attend, and we welcome interest from exhibitors too.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Bristol Myers Squibb - Director, Statistical Methodology and Innovation
Lead the development of innovative statistical methods, provides expert consulting, oversees tools and software, and mentors team members while collaborating cross-functionally to address complex drug development challenges.
nQuery (Statistical Solutions) - Research Biostatistian
We're looking for a Biostatistician who thrives at the intersection of academic rigour and real-world software impact with a strong grounding in statistics and hands-on experience in biostatistics, clinical trials, or a closely related field
As a Senior Statistician, you will provide high-quality statistical support to one of our key-FSP clients. At Senior level you may also take on a supervisory role (e.g. line management and/or project management), depending on your experience and interest.
This position is deal for a statistician who values ownership, collaboration, and using data to enable confident development decisions and to support regulatory submissions.